The COVID-19 Long Haul Foundation

Treatment, Referral & Educational Support for COVID-19 Illnesses & Vaccine Injury

Three years on, COVID-19 and the skin: long-term impacts

Esther E Freeman , Ignacio Garcia-Doval , Luigi Naldi , Roderick J Hay British Journal of Dermatology, Volume 189, Issue 1, July 2023, Pages 1–3, https://doi.org/10.1093/bjd/ljad131 In early 2020 there were reports of a new and potentially fatal […]

Three years on, COVID-19 and the skin: long-term impacts, emerging trends and clinical practice 

Esther E Freeman, Ignacio Garcia-Doval, Luigi Naldi, Roderick J Hay, British Journal of Dermatology, Volume 189, Issue 1, July 2023, Pages 1–3, https://doi.org/10.1093/bjd/ljad131 In early 2020 there were reports of a new and potentially […]

Common skin signs of COVID-19 in adults: An update

Samantha Polly, MD and Anthony P. Fernandez, MD, PhD, Cleveland Clinic Journal of Medicine, 89 (3) 161-167; DOI: https://doi.org/10.3949/ccjm.89a.2112 ABSTRACT Cutaneous findings can be clues to diagnosis and infection severity in viral illnesses, including COVID-19. The authors provide an update […]

Skin Manifestations in COVID-19 Patients: Are They Indicators for Disease Severity? A Systematic Review

Parnian Jamshidi, Bahareh Hajikhani, Mehdi Mirsaeidi, Hassan Vahidnezhad, Masoud Dadashi, Mohammad Javad Nasiri; Front. Med., 16 February 2021Sec. Infectious Diseases – Surveillance, Prevention and Treatment Volume 8 – 2021 | https://doi.org/10.3389/fmed.2021.634208 Introduction: Until now, […]

Chronic Spontaneous Urticaria Following COVID-19 Vaccination: A Case Report and Discussion on Allergic Reactions and Vaccine Safety

Jesus Ivan Martinez-Ortega1 and Felipe de Jesus Perez Hernandez2 Cureus. 2023 Sep; 15(9): e44860. Published online 2023 Sep 7. doi: 10.7759/cureus.44860 PMCID: PMC10560097 PMID: 37809203 Abstract This case report examines a rare occurrence of chronic spontaneous urticaria […]

Skin reactions to COVID-19 vaccines?  

2020-January 18 The coronavirus disease 2019 (COVID-19) pandemic has led to the development and approval of vaccines against the responsible virus — severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). More than 100 companies and institutions worldwide have developed vaccine […]